Drug Database
Back to search

United States· US:0009-0107_7e2f3780-88ee-4971-a4ab-3d6cd972c42c

Lincocin

A lincomycin product containing lincomycin hydrochloride, registered in United States by Pharmacia & Upjohn Company LLC. The same ATC class is registered in 5 of our 19 countries.

ATC J01FF02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLincocinATCJ01FF02REGISTER NO.US:0009-0107_7e2f3780…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lincomycin hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lincomycin is registered in 5 of 19 countries.

Countries holding a registration under ATC J01FF02 (lincomycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose
Search lincomycin products by name

Lincomycin · ATC J01FF02

5 / 19 countries

  • Belgiumprice
  • Italyprice
  • Japan
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LINCOMYCIN HYDROCHLORIDE
Manufacturer
Pharmacia & Upjohn Company LLC
Country
United States (US)
ATC code
J01FF02
ATC class
Lincomycin
Defined daily dose
1.8 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0009010704
    1 VIAL in 1 CARTON (0009-0107-04) / 10 mL in 1 VIAL
  • ndc11
    0009-0107-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for lincomycin.

Graded by severity as the source publishes them — 11 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lincomycin against other medicinesHow interaction checks work

Lincomycin · interactions on record

31 records

  • 11 moderate
  • 20 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • KaolinA07BC02moderate
  • AttapulgiteA07BC04moderate
  • BalsalazideA07EC04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lincomycin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lincomycin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Belgium · Lincocin
  • Bulgaria · Линкомицин Абр
  • Cyprus · Comycin, Lincomed
  • Spain · Lincocin
  • Greece · Pecasolin
  • Italy · Lincocin
  • Lithuania · Lincocin
  • Luxembourg · Lincocin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ab02a980-e93f-4ff8-832a-adbf142dde76
GET /v1/drugs/ab02a980-e93f-4ff8-832a-adbf142dde76?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL",
  "source": "ndc",
  "strength": "300",
  "substance": "LINCOMYCIN HYDROCHLORIDE",
  "productndc": "0009-0107",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA050317",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about lincomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console